title: Osmolarity regulates chondrogenic differentiation potential of synovial fluid derived mesenchymal progenitor cells.
abstract: Cartilage is one of few tissues where adult stem/progenitor cells have not been putatively identified. Recent studies have provided strong evidence that a sub-population of mesenchymal progenitor cells (MPCs) derived from the synovial fluid may be able to affect some degree of cartilage repair both in vivo and in vitro/ex vivo, however this does not appear to be the case in patients with arthritis. Previously, it has been found that synovial fluid osmolarity is decreased in patients with osteoarthritis (OA) or Rheumatoid arthritis (RA) and these changes in osmolarity have been linked to changes in chondrocyte gene regulation. However, it is yet unknown if changes in osmolarity regulate the gene expression in synovial fluid MPCs (sfMPCs), and by extension, chondrogenesis of this cell population. In the present study we have collected synovial fluid samples from normal, OA and RA knee joints, quantified the osmolarity of the fluid and modified the culture/differentiation media to span a range of osmolarities (264-375 mOsm). Chondrogenesis was measured with Alcian blue staining of cultures in addition to quantitative PCR (qPCR) using probes to Sox9, ACAN and Col2A1. Overall, sfMPCs from arthritic joints demonstrated decreased chondrogenic potential compared to sfMPCs isolated from normal synovial fluid. Furthermore, the sfMPCs retained increased chondrogenic potential if differentiated under the same osmolarity conditions for which they were initially derived within. In conclusion, it does appear the synovial fluid osmolarity regulates the chondrogenic potential of sfMPCs, however, further study is required to elucidate the mechanism by which the changes in osmolarity are sensed by the cells and regulate chondrogenic gene expression.
authors.affiliation: University of Calgary, Department of Cell Biology and Anatomy, Calgary, Alberta, Canada. karri.bertram@queensu.ca
authors.forename: Karri L
authors.initials: KL
authors.lastname: Bertram
authors.forename: Roman J
authors.initials: RJ
authors.lastname: Krawetz
mesh_terms: D000328:Adult; D053674:Aggrecans / Q000032:analysis / Q000096:biosynthesis; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology*; D019902:Chondrocytes / Q000737:chemistry / Q000166:cytology* / Q000378:metabolism; D020219:Chondrogenesis / Q000235:genetics / Q000502:physiology*; D024043:Collagen Type II / Q000032:analysis / Q000096:biosynthesis; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D009994:Osmolar Concentration; D055758:SOX9 Transcription Factor / Q000032:analysis / Q000096:biosynthesis; D013582:Synovial Fluid / Q000166:cytology*
chemical_list: C508319:ACAN protein, human; D053674:Aggrecans; C499177:COL2A1 protein, human; D024043:Collagen Type II; D055758:SOX9 Transcription Factor; C527932:SOX9 protein, human